Q3 2023 Holdings
Filed 2023-11-14 | 73 holdings | $1.9B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Mirati Therapeutics Inc(MRTXEUR) | Com | 60468T105 | $139.5M | 3,201,440 | 7.4% |
| Revolution Medicines Inc(RVMD) | Com | 76155X100 | $129.7M | 4,684,264 | 6.9% |
| BeiGene Ltd(ONC) | Sponsored ADR | 07725L102 | $89.9M | 500,000 | 4.8% |
| Tyra Biosciences Inc(TYRA) | Com | 90240B106 | $88.8M | 6,448,359 | 4.7% |
| Akero Therapeutics Inc(AKRO) | Com | 00973Y108 | $84.8M | 1,676,733 | 4.5% |
| Tango Therapeutics Inc(TNGX) | Com | 87583X109 | $80.2M | 7,123,642 | 4.3% |
| Springworks Therapeutics Inc | Com | 85205L107 | $79.1M | 3,421,541 | 4.2% |
| Sarepta Therapeutics Inc(SRPT) | Com | 803607100 | $72.7M | 600,000 | 3.9% |
| Apellis Pharmaceuticals Inc(APLS) | Com | 03753U106 | $65.7M | 1,726,000 | 3.5% |
| Cytokinetics Inc(CYTK) | Com New | 23282W605 | $61.9M | 2,100,000 | 3.3% |
| Ideaya Biosciences Inc(IDYA) | Com | 45166A102 | $59.4M | 2,202,812 | 3.2% |
| Nuvalent Inc(NUVL) | Com | 670703107 | $55.6M | 1,210,192 | 3.0% |
| ImmunoGen Inc(IMGNEUR) | Com | 45253H101 | $47.0M | 2,961,000 | 2.5% |
| Merus N V | Com | N5749R100 | $44.8M | 1,900,000 | 2.4% |
| Karuna Therapeutics Inc | Com | 48576A100 | $42.3M | 250,000 | 2.3% |
| Argenx SE(ARGX) | Sponsored ADR | 04016X101 | $41.8M | 85,000 | 2.2% |
| Legend Biotech Corp(LEGN) | Sponsored ADS | 52490G102 | $40.3M | 600,000 | 2.1% |
| Amylyx Pharmaceuticals Inc(AMLX) | Com | 03237H101 | $38.2M | 2,084,000 | 2.0% |
| Spdr Ser Tr(XBI) | S&P Biotech | 78464A870 | $36.5M | 500,000 | 1.9% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $30.2M | 625,000 | 1.6% |
| Rocket Pharmaceuticals Inc(RCKT) | Com | 77313F106 | $30.0M | 1,466,051 | 1.6% |
| Ventyx Biosciences Inc(VTYX) | Com | 92332V107 | $29.5M | 850,000 | 1.6% |
| Immunovant Inc(IMVT) | Com | 45258J102 | $28.8M | 750,000 | 1.5% |
| Arcus Biosciences Inc(RCUS) | Com | 03969F109 | $28.8M | 1,602,200 | 1.5% |
| Amicus Therapeutics Inc(FOLD) | Com | 03152W109 | $28.3M | 2,325,000 | 1.5% |
| Axsome Therapeutics Inc(AXSM) | Com | 05464T104 | $28.0M | 400,000 | 1.5% |
| Exelixis Inc(EXEL) | Com | 30161Q104 | $25.1M | 1,150,000 | 1.3% |
| AnaptysBio Inc(ANAB) | Com | 032724106 | $23.3M | 1,300,000 | 1.2% |
| Sage Therapeutics Inc(SG7) | Com | 78667J108 | $22.5M | 1,094,000 | 1.2% |
| Viking Therapeutics Inc(VKTX) | Com | 92686J106 | $22.1M | 2,000,000 | 1.2% |
| Xenon Pharmaceuticals Inc(XENE) | Com | 98420N105 | $20.5M | 600,000 | 1.1% |
| iTeos Therapeutics Inc(5E7) | Com | 46565G104 | $19.8M | 1,804,058 | 1.1% |
| PMV Pharmaceuticals Inc(PMVP) | Com | 69353Y103 | $19.4M | 3,163,795 | 1.0% |
| Iovance Biotherapeutics Inc(IOVA) | Com | 462260100 | $16.9M | 3,705,133 | 0.9% |
| Point Biopharma Global Inc | Com | 730541109 | $16.7M | 2,500,000 | 0.9% |
| Kalvista Pharmaceuticals Inc(KALV) | Com | 483497103 | $15.9M | 1,650,000 | 0.8% |
| Relay Therapeutics Inc(RLAY) | Com | 75943R102 | $15.3M | 1,819,132 | 0.8% |
| Madrigal Pharmaceuticals Inc(MDGL) | Com | 558868105 | $14.6M | 100,000 | 0.8% |
| Day One Biopharmaceuticals I(DAWN) | Com | 23954D109 | $14.6M | 1,189,943 | 0.8% |
| Oric Pharmaceuticals Inc(ORIC) | Com | 68622P109 | $10.5M | 1,732,571 | 0.6% |
| Cullinan Oncology Inc(CGEM) | Com | 230031106 | $9.7M | 1,074,082 | 0.5% |
| Nurix Therapeutics Inc(NRIX) | Com | 67080M103 | $9.6M | 1,224,892 | 0.5% |
| Acumen Pharmaceuticals Inc(ABOS) | Com | 00509G209 | $9.2M | 2,206,983 | 0.5% |
| Zentalis Pharmaceuticals Inc(ZNTL) | Com | 98943L107 | $9.0M | 450,000 | 0.5% |
| Ascendis Pharma A/S(ASND) | Sponsored ADR | 04351P101 | $8.9M | 95,000 | 0.5% |
| Enliven Therapeutics Inc(ELVN) | Com | 29337E102 | $8.8M | 646,058 | 0.5% |
| Prelude Therapeutics Inc(PRLD) | Com | 74065P101 | $7.7M | 2,495,018 | 0.4% |
| Avidity Biosciences Inc(RNA) | Com | 05370A108 | $7.2M | 1,121,327 | 0.4% |
| Geron Corp(GERN) | Com | 374163103 | $6.4M | 3,000,000 | 0.3% |
| Gossamer Bio Inc(GOSS) | Com | 38341P102 | $5.4M | 6,497,700 | 0.3% |